These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15841634)

  • 141. Imiquimod for Superficial Basal Cell Carcinomas.
    Mahatma G; Sweeney AR; Yen MT
    Int Ophthalmol Clin; 2020; 60(2):3-11. PubMed ID: 32205648
    [No Abstract]   [Full Text] [Related]  

  • 142. Immunotherapy of basal cell carcinoma: evolving approaches.
    Gaspari AA; Sauder DN
    Dermatol Surg; 2003 Oct; 29(10):1027-34. PubMed ID: 12974699
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Letter to the editor submitted in response to "efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial".
    Axon E; Grindlay DJ
    J Dermatolog Treat; 2021 Jun; 32(4):410. PubMed ID: 31437067
    [No Abstract]   [Full Text] [Related]  

  • 144. Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma.
    Sabri AH; Cater Z; Gurnani P; Ogilvie J; Segal J; Scurr DJ; Marlow M
    Int J Pharm; 2020 Nov; 589():119808. PubMed ID: 32891716
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry.
    Manoli SM; Moutsoudis A; Papageorgiou C; Lallas K; Rigas HM; Kyrmanidou E; Papadimitriou I; Paschou E; Spyridis I; Gkentsidi T; Sotiriou E; Vakirlis E; Ioannidis D; Apalla Z; Lallas A
    Dermatol Ther; 2020 Nov; 33(6):e14414. PubMed ID: 33064345
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.
    Kilgour JM; Shah A; Urman NM; Eichstadt S; Do HN; Bailey I; Mirza A; Li S; Oro AE; Aasi SZ; Sarin KY
    Clin Cancer Res; 2021 Sep; 27(17):4717-4725. PubMed ID: 34362809
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream.
    Zou Y; Zhu X; Xia R
    Dermatol Pract Concept; 2022 Nov; 12(4):e2022207. PubMed ID: 36534551
    [TBL] [Abstract][Full Text] [Related]  

  • 148. A systematic review of observational management of cutaneous basal cell carcinoma.
    Goodall R; Chicco M; Wietek N; Borsky K; Harrison C; Rodrigues J
    J Plast Reconstr Aesthet Surg; 2022 Jul; 75(7):2277-2285. PubMed ID: 35680535
    [TBL] [Abstract][Full Text] [Related]  

  • 149. The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers.
    Gaitanis G; Zampeta A; Tsintzou P; Fillis G; Seretis K; Feldmeyer L; Bassukas I
    Curr Oncol; 2022 Nov; 29(11):8475-8482. PubMed ID: 36354728
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
    Alipour S; Gholami B; Orouji M; Heydari S
    Daru; 2024 Jun; 32(1):443-447. PubMed ID: 38151679
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Candida antigen in the treatment of basal cell carcinoma.
    Aftergut K; Curry M; Cohen J
    Dermatol Surg; 2005 Jan; 31(1):16-8. PubMed ID: 15720089
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Plasmacytoid dendritic cells lead the charge against tumors.
    Jiménez-Baranda S; Silva IP; Bhardwaj N
    J Clin Invest; 2012 Feb; 122(2):481-4. PubMed ID: 22251700
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
    Pitney T; Muir J
    J Am Acad Dermatol; 2021 Jan; 84(1):e55. PubMed ID: 32860912
    [No Abstract]   [Full Text] [Related]  

  • 154. Reply to: Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
    Sinx K; Mosterd K
    J Am Acad Dermatol; 2021 Jan; 84(1):e57. PubMed ID: 32861711
    [No Abstract]   [Full Text] [Related]  

  • 155. Superficial Basal Cell Carcinoma on the Back Region Treated with a Combination of Cryotherapy and 5% Imiquimod Cream: A Case Report.
    Sutedja EK; Elgianda GS; Sutedja E; Ruchiatan K
    Int Med Case Rep J; 2023; 16():391-396. PubMed ID: 37398930
    [TBL] [Abstract][Full Text] [Related]  

  • 156. The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.
    Schön MP; Schön M
    Expert Opin Ther Targets; 2006 Feb; 10(1):69-76. PubMed ID: 16441229
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Management of superficial basal cell carcinoma: focus on imiquimod.
    Raasch B
    Clin Cosmet Investig Dermatol; 2009 Jun; 2():65-75. PubMed ID: 21436969
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Management of patients with giant basal cell carcinoma during SARS COV2 outbreak in Italy.
    Cantisani C; Rossi R; Nisticò SP; Vitiello M; Farnetani F; Bennaro L; Pellacani G
    Transl Biophotonics; 2022 Aug; 4(3):e202200009. PubMed ID: 35942364
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response.
    Roldán-Marín R; Toussaint-Caire S
    Dermatol Ther (Heidelb); 2015 Dec; 5(4):265-272. PubMed ID: 26538104
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Different Anatomical Distribution of Basal Cell Carcinoma Subtypes in Iranian Population: Association between Site and Subtype.
    Ghanadan A; Abdollahi P; Rabet M; Naraghi Z; Abbasi MA; Moslehi H; Abbasi A
    Ann Dermatol; 2014 Oct; 26(5):559-63. PubMed ID: 25324646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.